Literature DB >> 2962925

Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.

P N Rao1, N A Heerema, C G Palmer.   

Abstract

The frequencies of common fragile sites (c-fra) induced in peripheral blood lymphocytes by fluorodeoxyuridine (FUdR), aphidicolin, or caffeine, in eight healthy controls were studied. There was a significantly higher frequency of breaks (P less than 0.05) in the latter two treatments than the former. Also, significant variation in total number of breaks was observed among the eight individuals within the three treatments. The relative frequency of a fragile site in relation to the total number of fragile sites in an individual rather than its expression in total cells was considered important. Use of a frequency of 4% or more of total fragile sites was proposed to eliminate apparent "random" breaks that were observed. Using these criteria, a total of 31 c-fra were observed in the three treatments. The distribution of the fragile sites was different in FUdR-treated cells as opposed to caffeine- and aphidicolin-treated cells. Sites 3p14 and 16q23 and Xp22 were the three most frequently observed c-fra. The higher frequency of expression of some fragile sites in normal controls, as observed here, suggests that any relationship between fragile sites and neoplastic transformation has to be carefully evaluated. A classification based on frequency in the population, rather than mode of induction, is suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962925     DOI: 10.1007/bf00291228

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Clinical implications and classification of the constitutive fragile sites.

Authors:  A Daniel
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

Review 2.  Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites.

Authors:  A de la Chapelle; R Berger
Journal:  Cytogenet Cell Genet       Date:  1984

3.  A new familial "fragile site" on chromosome 16 (q23-24). Cytogenetic and clinical considerations.

Authors:  F Shabtai; D Klar; R Nissimov; D Vardimon; J Hart; I Halbrecht
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  Constitutive fragile sites 1p31, 3p14, 6q26, and 16q23 and their use as controls for false-negative results with the fragile(X).

Authors:  A Daniel; L Ekblom; S Phillips
Journal:  Am J Med Genet       Date:  1984-07

5.  Comparative analysis of caffeine and 3-aminobenzamide as DNA repair inhibitors in Syrian baby hamster kidney cells.

Authors:  S K Das; C C Lau; A B Pardee
Journal:  Mutat Res       Date:  1984-02       Impact factor: 2.433

6.  DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.

Authors:  T W Glover; C Berger; J Coyle; B Echo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Constitutive fragile sites and cancer.

Authors:  J J Yunis; A L Soreng
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

8.  Familial fragile site found at the cancer breakpoint (1)(q32). Inducibility by distamycin A, concomitance with fragile (16)(q22).

Authors:  F Shabtai; J Hart; D Klar; I Halbrecht
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

9.  The most common fragile site in man is 3p14.

Authors:  D F Smeets; J M Scheres; T W Hustinx
Journal:  Hum Genet       Date:  1986-03       Impact factor: 4.132

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more
  14 in total

1.  Increased expression of 5q31 fragile site in a Bloom syndrome family.

Authors:  A F Fundia; N B Gorla; M M Bonduel; O Azpilicueta; H Lejarraga; F S Muriel; I B Larripa
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

2.  Neither age nor sex influence the expression of folate sensitive common fragile sites on human chromosomes.

Authors:  D F Smeets; G Merkx
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

3.  Telomere association of chromosomes induced by aphidicolin in a normal individual.

Authors:  C Fuster; R Miró; L Barrios; J Egozcue
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

4.  Genetic determination of fragile-site expression.

Authors:  D Smeets; A Arets
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

5.  Population cytogenetics of aphidicolin-induced fragile sites.

Authors:  B Tedeschi; P Vernole; M L Sanna; B Nicoletti
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

6.  Changes of common fragile sites on chromosomes according to the menstrual cycle.

Authors:  T Furuya; J Hagiwara; H Ochi; H Tokuhiro; R Kikawada; T Karube; S Watanabe
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

7.  Cytogenetic studies in motile sperm from normal men.

Authors:  J Benet; A Genescà; J Navarro; J Egozcue; C Templado
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

8.  Fragile sites and statistics.

Authors:  T Mariani
Journal:  Hum Genet       Date:  1989-03       Impact factor: 4.132

9.  Variability in expression of common fragile sites: in search of a new criterion.

Authors:  D K Jordan; T L Burns; J E Divelbiss; R F Woolson; S R Patil
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

10.  Expression of folate-sensitive fragile sites in lymphocyte chromosomes.

Authors:  C Fuster; R Miró; C Templado; L Barrios; J Egozcue
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.